Connect with us


Gilead to test inhaled form of COVID-19 drug to widen its use – msnNOW

Gilead Sciences Inc. said it plans to start human trials of an inhaled version of its anti-Covid-19 drug remdesivir, a move that could significantly expand its use if successful.



© Bloomberg
Signage is displayed outside Gilead Sciences Inc. headquarters in Foster City, California, U.S., on Thursday, March 19, 2020. Gilead Sciences stock jumped as much as 7% on Thursday, rea…

Click here to view the original article.